Stonebridge Capital Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$4K 1142
2022
Q3
$4K Hold
200
﹤0.01% 726
2022
Q2
$4K Hold
200
﹤0.01% 752
2022
Q1
$3K Hold
200
﹤0.01% 873
2021
Q4
$4K Hold
200
﹤0.01% 789
2021
Q3
$4K Sell
200
-200
-50% -$4.59K ﹤0.01% 758
2021
Q2
$11K Buy
400
+200
+100% +$5.6K ﹤0.01% 740
2021
Q1
$6K Buy
+200
New +$6.82K ﹤0.01% 722
2020
Q3
Sell
-200
Closed -$4K 766
2020
Q2
$4K Hold
200
﹤0.01% 605
2020
Q1
$2K Sell
200
-1
-0.5% -$11 ﹤0.01% 676
2019
Q4
$3K Hold
201
﹤0.01% 712
2019
Q3
$2K Hold
201
﹤0.01% 754
2019
Q2
$5K Buy
+201
New +$5.79K ﹤0.01% 688

Other funds holding CVET

Stonebridge Capital Advisors's CVET Position: Q4 2022 in Review

Stonebridge Capital Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 200 shares — an estimated $4K sold.

Stonebridge Capital Advisors first reported a position in CVET in Q2 2019 and held it in 12 quarters. The position peaked at $11K in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Stonebridge Capital Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 200 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $4K.
  • Stonebridge Capital Advisors first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • Stonebridge Capital Advisors's Covetrus, Inc. Common Stock position peaked at $11K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.